Overview

Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

The primary goal of this study is to determine the clinical advantage of pre-treatment with mifepristone in second trimester misoprostol induction abortion. This will be a randomized controlled double-blinded trial of 120 women in each country comparing misoprostol alone to mifepristone plus misoprostol for second trimester (14-21 weeks' LMP) medical abortion.

Phase:

N/A

Details

Lead Sponsor:

Gynuity Health Projects

Treatments:

Mifepristone
Misoprostol